Anti-CD19 panCARTM program (ORN-252) demonstrated robust B cell depletion with significant reduction in anti-dsDNA titers in humanized lupus ...

Vascarta Inc., is pleased to share results from a new study led by researchers at the U.S. Food and Drug Administration's ...

A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of Bonn makes spatial ...

Findings set the stage for further investigation of hSFRP2 mAb as a targeted therapy for triple-negative breast cancer.

Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial to evaluate ARV-393 plus glofitamab as ...

A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of Bonn makes spatial ...

Adding spironolactone to HIV treatment shows promise in accelerating viral decay and reducing inflammation linked to chronic ...

An international team led by two Université de Montréal researchers unveiled how a molecule capable of opening the "shell" of HIV, improves the ...

Addressing Current Limitations in Spatial OmicsExisting tools for spatial proteomics often have constraints. Many are not equipped to predict multiple ...

Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial to evaluate ARV-393 plus glofitamab as a ...

Triple-negative breast cancer (TNBC) is one of the hardest breast cancers to treat because it grows quickly, spreads early and often becomes resistant to therapy. In a new preclinical study, ...

An international team led by two Université de Montréal researchers has unveiled how a molecule capable of opening the "shell ...